NPPA Cuts Prices of 543 Cancer Drugs: 73% Reduced, MRP Cap of 30% Trade Margin Effective from 9 November
The National Pharmaceutical Pricing Authority (NPPA) has revised the Maximum Retail Prices (MRP) for 543 cancer drug brands/packs. 73% of these (397 drugs) have seen price reductions, with 217 slashed by over 50%. This follows a government order capping the trade margin for 137 anti-cancer drugs at 30% of MRP. The new prices come into effect from 9 November 2026.
29 October 2026,

